EUVIMEDEUVIMED entdecken
Crossref

Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet

Sakshi Misra, Prabha Rajput, Amandeep Kaur

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-03827-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sakshi Misra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, ISF College of Pharmacy, Ghal Kalan, GT Road, Moga, 142001, Punjab, India. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Diabetes Mellitus, Type 2, Neuroprotective Agents, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In examining the enduring consequences of diabetes, recent research has focused on the anticipated outcomes of the condition. Specifically, cognitive impairment has been linked to diabetes mellitus dating back to the discovery of insulin. This study delves into the neuroprotective effects of TZP, i.e. tirzepatide a dual GIP and GLP-1 receptor agonist that works by mimicking these two gut hormones, against cognitive impairment associated with type 2 diabetes mellitus (T2DM). T2DM-like zebrafish model of varying age groups was created through a 6-week administration of a high-fat diet (HFD). Parameters such as body weight, body mass index, and blood glucose levels were monitored, and behavioural assessments (T-maze, novel tank diving test, and inhibitory avoidance test) were conducted at the conclusion of the protocol to assess learning and memory. Additionally, lipid profile biochemical parameters (MDA, AChEs, and GSH), molecular markers (IL-1β, IL-10, TNF-α, Bcl-2, Bax, GSK-3β, and AMPK), and histopathological examinations were performed. Treatment with the novel GLP-1 and GIP dual agonist TZP (10 nM/kg, i.p.) significantly ameliorated cognitive impairment, as evidenced by behavioural parameters, and restored antioxidant like GSH (p < 0.05) and catalase (p < 0.05) and anti-inflammatory marker levels, i.e. IL-10 (p < 0.05) compared to the HFD group. TZP also mitigated abnormal glucose (73.2 ± 5.889) and lipid profiles (TG 0.159 ± 0.0075 and TC 0.100 ± 0.0020) in hyperglycaemic zebrafish. This study suggests that the positive effects of TZP on cognition and memory may stem from its neuroprotective capabilities, potentially attributed to its antioxidant, anti-inflammatory, and anti-apoptotic properties, as well as its ability to enhance AMPK levels as GLP-1 agonist has the potential to increase the level of AMPK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionDiabetes Mellitus, Type 2Neuroprotective AgentsHypoglycemic AgentsCognitionAnimalsZebrafishDiet, High-FatDisease Models, AnimalGlucagon-Like Peptide-1 Receptor AgonistsGastric Inhibitory PolypeptideBehavior, AnimalMaze LearningMaleBlood GlucoseTirzepatide

Stichwörter der Autor:innen

Cognitive impairmentDiabetes mellitusNeurodegenerationTirzepatideZebrafish

Substanzen

Neuroprotective AgentsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsGastric Inhibitory PolypeptideBlood GlucoseTirzepatide

Autor:innen und Institutionen

  • Department of Pharmacology, ISF College of Pharmacy, Ghal Kalan, GT Road, Moga, 142001, Punjab, India.
  • Department of Pharmacology, ISF College of Pharmacy, Ghal Kalan, GT Road, Moga, 142001, Punjab, India. prabharajput1351991@gmail.com.
  • Department of Pharmacology, School of Pharmacy & Technology Management, SVKM's NMIMS University, Shirpur Campus, Shirpur, India. prabharajput1351991@gmail.com.

Zitieren

APA

Misra, S., Rajput, P., & Kaur, A. (2025). Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03827-3

Vancouver

Misra S, Rajput P, Kaur A. Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03827-3

BibTeX
@article{Misra2025,
  author = {Misra, Sakshi and Rajput, Prabha and Kaur, Amandeep},
  title = {Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-03827-3}
}
Kostenlos starten →